NEW BRUNSWICK SCIENTIFIC CO., INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
Three Months Ended Year Ended
December 31, December 31,
2001 2000 2001 2000
Net sales $17,253 $14,545 $60,294 $49,864
Operating costs and
expenses:
Cost of sales 10,180 8,726 36,265 29,710
Selling, general and
administrative
expenses 4,309 3,908 16,205 15,607
Research, development
and engineering
expenses 702 792 2,751 3,423
DGI research expenses -- 864 1,312 3,480
Non-recurring
severance costs -- -- 260 --
Total operating costs
and expenses 15,191 14,290 56,793 52,220
Income (loss) from
operations 2,062 255 3,501 (2,356)
Other income (expense):
Interest income 11 20 56 56
Interest expense (124) (170) (561) (638)
Other, net (37) (16) (113) (87)
Write-off of investment -- -- -- (950)
(150) (166) (618) (1,619)
Income (loss) before
income tax expense
(benefit)
and equity in
operations of DGI 1,912 89 2,883 (3,975)
Income tax expense
(benefit) 42 57 145 (48)
Income (loss) before
equity in operations
of DGI 1,870 32 2,738 (3,927)
Equity in operations
of DGI (34) -- (527) --
Net income (loss) $ 1,836 $32 $2,211 $ (3,927)
Basic income (loss)
per share $.27 $-- $.33 $(.59)
Diluted income (loss)
per share $.27 $-- $.33 $(.59)
Basic weighted average
number of
shares outstanding 6,749 6,703 6,738 6,640
Diluted weighted average
number of shares
outstanding 6,826 6,831 6,772 6,640
SOURCE: New Brunswick Scientific Co., Inc. |
